Jun Kawai
Direktor/Vorstandsmitglied bei LINICAL CO., LTD.
Vermögen: 2 Mio $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Jun Kawai
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Miscellaneous Commercial Services | 15 | |
Linical Taiwan Co. Ltd.
4
| Subsidiary | 4 | |
Linical China Co. Ltd.
1
| Subsidiary | 1 | |
Linical Europe Holding GmbH
 Linical Europe Holding GmbH Medical/Nursing ServicesHealth Services Part of Linical Co., Ltd., Linical Europe Holding GmbH operates as a holding German company with interests in pharmaceutical research and development. The company is based in Frankfurt, Germany. The CEO of the company is Isao Sakamoto. Linical Europe Holding was acquired by Linical Co., Ltd. from ADCURAM Invest GmbH on December 01, 2014 for $8.20 million.
1
| Subsidiary | Medical/Nursing Services | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jun Kawai
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| Linical Accelovance America, Inc. | Chairman Director/Board Member Director/Board Member | ||
Linical USA, Inc.
 Linical USA, Inc. Miscellaneous Commercial ServicesCommercial Services Linical USA, Inc. provides research services. The company is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member Director/Board Member | |
| ASTELLAS PHARMA INC. | Pharmaceuticals: Major | Chairman Investor Relations Contact | |
Linical Korea Co., Ltd.
 Linical Korea Co., Ltd. BiotechnologyHealth Technology Part of Linical Co., Ltd., Linical Korea Co., Ltd. is a South Korean company that provides contract research organization (CRO) services to pharmaceutical companies. The company is based in Seoul, South Korea. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Tokyo | College/University | Undergraduate Degree | |
| MITSUI FUDOSAN CO., LTD. | Real Estate Development | Director/Board Member | |
| DAICEL CORPORATION | Chemicals: Specialty | Director/Board Member | |
| Tokyo Metropolitan Public University Corp. | College/University | Undergraduate Degree | |
Nippon Boehringer Ingelheim Co., Ltd.
 Nippon Boehringer Ingelheim Co., Ltd. Pharmaceuticals: MajorHealth Technology Established in 1961, Nippon Boehringer Ingelheim Co., Ltd. develops, manufactures, imports and markets pharmaceutical products. The company is also involved in the importation and exportation of intermediates and bulk pharmaceutical products. Nippon Boehringer Ingelheim is based in Tokyo and operates in several parts of Japan through its domestic offices. | Pharmaceuticals: Major | President | |
Novartis Pharma KK
 Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Novartis Pharma KK develops, imports, produces and sells pharmaceutical products. The company was founded on April 1, 1997 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Tsukuba | College/University | Graduate Degree |
Statistik
International
| Japan | 11 |
| Vereinigte Staaten | 3 |
| Südkorea | 2 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 4 |
| Commercial Services | 2 |
| Finance | 2 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 32 |
| Independent Dir/Board Member | 9 |
| Corporate Officer/Principal | 7 |
| President | 7 |
| Chairman | 3 |
